Personalized Vaccine Shows Promise for Follicular Lymphoma Patients

August 28, 2009

Oncology Times

The Oncology Times highlights a trial presented by Stephen Schuster, MD, an associate professor of Medicine at the Abramson Cancer Center, in this year's American Society of Clinical Oncology (ASCO) meeting showing that a personalized vaccine made from a patient's own tumor cells improves progression-free survival among patients with follicular lymphoma... Read More